Hepatitis C Virus (HCV) Chimeric Ag >95%

The recombinant chimeric antigen expressed for Hepatitis C Virus diagnostics combines immunodominant epitopes from conserved viral regions into a single fusion construct, raising antibody recognition breadth beyond what any single fragment achieves. Supplied at greater than 95% purity by SDS-PAGE assessment, this preparation is calibrated for use as both a coating reagent and a reference standard in anti-HCV immunoassay development at Antibodies.com.

Each 1 mg aliquot is presented as a liquid formulation in a sealed vial. The antigen retains binding activity suitable for ELISA plate coating, where it captures circulating anti-HCV antibodies from clinical specimens with reproducible signal-to-noise ratios across multiple viral genotypes.

Chimeric constructs of this kind are routinely applied during assay validation to confirm epitope coverage, to evaluate cross-reactivity against related flaviviruses, and to generate positive-control sera for internal quality monitoring in diagnostic workflows.